Myriad Genetics Inc (MYGN)
Healthcare
Diagnostics & Research
2.90 $
-46.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Myriad Genetics Inc (MYGN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 91.0% of the shares are freely tradable; institutional investors hold 97.4%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
97.4%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
3.8%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
91.0%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
9.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
94Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 9.41 | 8,889,644 | -41.9 | 03/31/2026 |
| Vanguard Group Inc | 8.71 | 8,225,371 | +4.3 | 12/31/2025 |
| Millennium Management LLC | 7.06 | 6,668,817 | -0.5 | 03/31/2026 |
| Glenview Capital Management LLC | 5.73 | 5,411,978 | +18.0 | 03/31/2026 |
| D. E. Shaw & Co LP | 4.76 | 4,499,724 | -0.1 | 03/31/2026 |
| State Street Corp | 4.68 | 4,424,027 | -25.9 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.16 | 3,924,525 | +0.0 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 3.36 | 3,168,742 | -12.2 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 2.73 | 2,582,231 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.94 | 2,776,877 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.